Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04918576
Other study ID # 13103
Secondary ID
Status Not yet recruiting
Phase Phase 3
First received
Last updated
Start date August 2022
Est. completion date August 2024

Study information

Verified date April 2022
Source McMaster University
Contact Yaeesh Sardiwalla, MD
Phone 90505221155
Email yaeesh.sardiwalla@medportal.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hematoma is a common complication of bilateral breast reduction (BBR) surgery. This can lead to pain and discomfort experienced by the patient, in addition to greater use of valuable healthcare resources. Previous studies have shown correlation between the use of tranexamic acid (TXA), an anti-fibrinolytic, and reduced post-surgical bleeding complication events. In this randomized control trial (RCT) evaluation TXA use in BBR, for which one breast will be randomized to have TXA applied topically, while the other will have normal saline (NS) placebo applied. The primary objective of this prospective blinded randomized control trial study is to determine if the administration of topical TXA in BBR reduces the incidence of surgical site hematoma compared to placebo within 2 weeks following surgery. The results of this study will be used to inform the design of a larger multicentered RCT on TXA in breast surgery.


Description:

The primary objective of this study is to investigate the use of topical application of tranexamic Acid (TXA) to the surgical wound as a means to decrease hematoma formation compared to placebo in patients undergoing bilateral breast reduction (BBR). This project is designed as a single-center RCT to evaluate the effectiveness of topical TXA in this patient population. If enrolled in this study, patients individual breasts will be randomly assigned to one of two treatment groups for to apply to the wound before it is closed. One breast will have an intravenous form of TXA applied topically to the surgical site. The other will be have a topical normal saline solution applied to the wound before closure (a placebo). The patients will have the standard number of drains and postoperative instructions for breast reduction. They will follow-up at two weeks time in clinic for assessment, and emergency room visits will be also be evaluated. Standard of care will be practiced with respect to all procedures and visits.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 106
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Are 18 years or older; - Are undergoing bilateral breast reduction at either Hamilton Health Sciences or St. Joseph's Hospital Hamilton. Exclusion Criteria: - Taking therapeutic anticoagulation; - Taking antiplatelet drugs; - Pregnant or breast feeding; - Allergic to TXA; - Cannot provide informed consent; - Have a documented coagulopathy or bleeding disorder, acquired disturbances of colour vision, subarachnoid hemorrhage, hematuria, irregular menstrual bleeding, or seizure disorder.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Tranexamic acid
3 grams of tranexamic acid (30mL of 100 mg/mL solution) diluted in 10 mL of normal saline
Normal Saline
40 mL topical of 0.9% normal saline

Locations

Country Name City State
Canada Juravinski Hospital, Hamilton Health Sciences Hamilton Ontario
Canada St. Joseph's Healthcare, Charlton Campus Hamilton Ontario
Canada St. Joseph's Healthcare, King Campus Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

References & Publications (10)

Bauermeister AJ, Gill K, Zuriarrain A, Earle SA, Newman MI. "Reduction mammaplasty with superomedial pedicle technique: A literature review and retrospective analysis of 938 consecutive breast reductions". J Plast Reconstr Aesthet Surg. 2019 Mar;72(3):410-418. doi: 10.1016/j.bjps.2018.12.004. Epub 2018 Dec 14. Review. — View Citation

De Bonis M, Cavaliere F, Alessandrini F, Lapenna E, Santarelli F, Moscato U, Schiavello R, Possati GF. Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg. 2000 Mar;119(3):575-80. — View Citation

DeFazio MV, Fan KL, Avashia YJ, Tashiro J, Ovadia S, Husain T, Camison L, Panthaki ZJ, Salgado CJ, Thaller SR. Inferior pedicle breast reduction: a retrospective review of technical modifications influencing patient safety, operative efficiency, and postoperative outcomes. Am J Surg. 2012 Nov;204(5):e7-14. doi: 10.1016/j.amjsurg.2012.07.015. — View Citation

Derby BM, Grotting JC, Redden DT. Vertical Sculpted Pillar Reduction Mammaplasty in 317 Patients: Technique, Complications, and BREAST-Q Outcomes. Aesthet Surg J. 2016 Apr;36(4):417-30. doi: 10.1093/asj/sjv217. Epub 2016 Feb 23. — View Citation

Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am. 2014 Dec 3;96(23):1937-44. doi: 10.2106/JBJS.N.00060. — View Citation

Ipema HJ, Tanzi MG. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother. 2012 Jan;46(1):97-107. doi: 10.1345/aph.1Q383. Epub 2011 Dec 27. Review. — View Citation

Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012 May 17;344:e3054. doi: 10.1136/bmj.e3054. Review. — View Citation

Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee. 2014 Dec;21(6):987-93. doi: 10.1016/j.knee.2014.09.010. Epub 2014 Oct 23. Review. — View Citation

Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J Arthroplasty. 2013 Aug;28(7):1080-3. doi: 10.1016/j.arth.2012.11.016. Epub 2013 Mar 28. — View Citation

Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am. 2010 Nov 3;92(15):2503-13. doi: 10.2106/JBJS.I.01518. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Hematoma Incidence rate of hematoma 2 weeks
Primary Seroma Incidence rate of seroma 2 weeks
Secondary Drain output Total drain output (mL) at 24 hours 24 hours
Secondary Days with drains Total number of days drains in situ with standard discharge criteria 2 weeks
Secondary Reoperation rate Number of repeat operations required for patient related to complication 2 weeks
Secondary Reintervention rate Rate of subsequent interventions including aspiration, repeat drain insertion or other 2 weeks
Secondary Imaging findings Ultrasound findings of hematoma or seroma, if applicable 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT06280456 - Tranexamic Acid Injection With Different Drainage Clamping Time After Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT06067217 - Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users N/A
Completed NCT03113253 - TRANexamic Acid to Reduce Bleeding in BURN Surgery Phase 4
Completed NCT02903017 - Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage Phase 4
Completed NCT02569658 - Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty N/A
Terminated NCT03085394 - Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery Phase 3
Completed NCT04911413 - Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery Phase 4
Recruiting NCT02938962 - Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X) Phase 4
Completed NCT01895101 - The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients Phase 4
Completed NCT02806024 - Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study Phase 4
Completed NCT03897621 - The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery N/A
Completed NCT03360045 - Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis Phase 4
Completed NCT06301204 - Effectiveness Of Tranexamic Acıd Application Wıth Different Doses On Bleeding, Edema And Physician Comfort In Orthognathıc Surgery Patients N/A
Completed NCT04025736 - Arthroscopic Shoulder Surgery With Administration of Intravenous Tranexamic Acid N/A
Completed NCT04427618 - Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section Phase 3
Not yet recruiting NCT05913466 - Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar TURP N/A
Recruiting NCT05230381 - Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection N/A
Completed NCT01980355 - TXA Study in Major Oncologic Surgery N/A
Not yet recruiting NCT06010368 - Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section Phase 3
Withdrawn NCT03433144 - The Effects of Tranexamic Acid on Blood Loss During Orthognathic Surgery Phase 4